Enter at least 3 characters
  • 05
    06/18
    NEWS
    Chiesi signs a deal with StartUp Health: first investment in the digital area
    Chiesi has signed a strategic deal with StartUp Health, a global health...
  • PRESS RELEASE
    Protalix BioTherapeutics Expands Partnership with Chiesi Farmaceutici to...
    Protalix grants Chiesi Ex-US rights for PRX-102, a chemically modified version of the recombinant protein alpha-Galactosidase-A...